脑活素对中度闭合性颅脑损伤大鼠长期组织学与功能恢复的随机对照试验
该随机、盲法、载体对照的临床前试验在中度闭合性颅脑损伤雄性Wistar大鼠中,伤后4小时开始每日腹腔注射脑活素2.5 ml/kg或生理盐水,持续10天。结果显示脑活素显著改善伤后1天至3个月的感觉运动功能及长达3个月的认知功能恢复,并减轻神经元丢失、轴索损伤和淀粉样前体蛋白积累,促进神经发生。
要点
- 脑活素2.5 ml/kg腹腔注射可改善中度CHI大鼠长期认知与感觉运动功能。
- 脑活素减轻海马DG和CA3区神经元丢失并促进神经发生。
- 组织学改善与功能恢复显著相关,提示神经可塑性与神经保护作用。
核心结论
- 脑活素治疗显著改善中度闭合性颅脑损伤大鼠的长期功能和组织学结局。
- 功能结局与神经可塑性和神经保护的组织学指标显著相关。
研究设计与样本
- 随机、盲法、载体对照的临床前试验。
- 雄性成年Wistar大鼠中度闭合性颅脑损伤模型。
- 脑活素组n=13,载体(生理盐水)组n=13,伤后4小时开始每日腹腔注射,持续10天。
- 伤后3个月处死,进行组织学分析。
主要发现
- 与生理盐水组相比,脑活素组齿状回神经母细胞和新生成熟神经元数量显著增加(p<0.05)。
- 脑活素组多个脑区淀粉样前体蛋白积累和轴索损伤减轻,海马齿状回和CA3区神经元丢失减少(p<0.05)。
- 广义估计方程显示脑活素组伤后1天至3个月感觉运动功能结局显著优于生理盐水组(p<0.05)。
- 脑活素组在社交互动、Morris水迷宫、新物体识别和气味识别测试中显示长达3个月的认知功能恢复显著改善。
- Pearson偏相关分析显示脑活素组多个组织学结局与伤后3个月功能恢复显著相关。
临床怎么用
- 提示脑活素可能对中度闭合性颅脑损伤具有治疗潜力,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors previously demonstrated that Cerebrolysin is effective for treatment of mild closed head injury (CHI) when administered 4 hours after injury. The aim of this study was to determine Cerebrolysin's effects on functional and histological outcomes in rats subjected to moderate CHI. METHODS: In this randomized, blinded, and vehicle-controlled preclinical trial, male adult Wistar rats subjected to moderate CHI received either Cerebrolysin treatment at a dose of 2.5 ml/kg (n = 13) or vehicle (saline, n = 13) intraperitoneally administered daily for 10 days, starting at 4 hours after injury. Animals were subjected to cognitive and sensorimotor functional tests at multiple time points, and they were killed 3 months after injury. The brains were processed for analyses of neuronal cell loss, amyloid precursor protein, axonal damage, and neurogenesis. RESULTS: Compared with rats treated with vehicle (saline), rats treated with Cerebrolysin had significantly increased numbers of neuroblasts and newborn mature neurons in the dentate gyrus (DG) and attenuated amyloid precursor protein accumulation and axonal damage in various brain regions, as well as decreased neuronal loss in the DG and cornu ammonis 3 (CA3) region of the hippocampus (p < 0.05). Global testing using generalized estimating equations showed a significant beneficial effect of Cerebrolysin treatment on sensorimotor functional outcomes from 1 day to 3 months after injury compared to that of saline treatment (p < 0.05). Compared with vehicle-treated rats, Cerebrolysin-treated rats showed significantly and robustly improved long-term (up to 3 months) cognitive functional recovery, as measured by social interaction, Morris water maze, novel object recognition, and odor recognition tests. In the Cerebrolysin-treated rats there were significant correlations between multiple histological outcomes and functional recovery evident 3 months after moderate CHI, as indicated by Pearson partial correlation analyses. CONCLUSIONS: The authors' findings demonstrate that Cerebrolysin treatment significantly improves long-term functional and histological outcomes in rats with moderate CHI, with functional outcomes significantly correlated with histological indices of neuroplasticity and neuroprotection. These data indicate that Cerebrolysin may be useful for the treatment of moderate CHI.
引用
- Zhang Y, Chopp M, Zhang Y, et al. Randomized controlled trial of Cerebrolysin's effects on long-term histological outcomes and functional recovery in rats with moderate closed head injury. J Neurosurg. 2019. PMID: 31491768. doi:10.3171/2019.6.JNS191027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。